Age-related clonal hematopoiesis

LI Shlush - Blood, The Journal of the American Society of …, 2018 - ashpublications.org
Age-related alterations in the human blood system occur in B cells, T cells, cells of the innate
system, as well as hematopoietic stem and progenitor cells (HSPCs). Interestingly, age …

The multifaceted role of autophagy in cancer and the microenvironment

H Folkerts, S Hilgendorf, E Vellenga… - Medicinal research …, 2019 - Wiley Online Library
Autophagy is a crucial recycling process that is increasingly being recognized as an
important factor in cancer initiation, cancer (stem) cell maintenance as well as the …

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

A Pellagatti, RN Armstrong, V Steeples… - Blood, The Journal …, 2018 - ashpublications.org
Abstract SF3B1, SRSF2, and U2AF1 are the most frequently mutated splicing factor genes in
the myelodysplastic syndromes (MDS). We have performed a comprehensive and …

Genetics of progression from MDS to secondary leukemia

AJ Menssen, MJ Walter - Blood, The Journal of the American …, 2020 - ashpublications.org
Our understanding of the genetics of acute myeloid leukemia (AML) development from
myelodysplastic syndrome (MDS) has advanced significantly as a result of next-generation …

Clinical implications of genetic mutations in myelodysplastic syndrome

JA Kennedy, BL Ebert - Journal of Clinical Oncology, 2017 - ascopubs.org
Myelodysplastic syndrome (MDS) is clonal disorder characterized by ineffective
hematopoiesis and a tendency to evolve into acute myeloid leukemia (AML). Genetic studies …

[HTML][HTML] Clonal evolution in myelodysplastic syndromes

P da Silva-Coelho, LI Kroeze, K Yoshida… - Nature …, 2017 - nature.com
Cancer development is a dynamic process during which the successive accumulation of
mutations results in cells with increasingly malignant characteristics. Here, we show the …

Clonal evolution in leukemia

AA Ferrando, C Lopez-Otin - Nature medicine, 2017 - nature.com
Human leukemias are liquid malignancies characterized by diffuse infiltration of the bone
marrow by transformed hematopoietic progenitors. The accessibility of tumor cells obtained …

Current and emerging strategies for management of myelodysplastic syndromes

C Saygin, HE Carraway - Blood reviews, 2021 - Elsevier
Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis with
varying degrees of dysplasia and peripheral cytopenias. MDS are driven by structural …

Stem and progenitor cell alterations in myelodysplastic syndromes

A Shastri, B Will, U Steidl… - Blood, The Journal of the …, 2017 - ashpublications.org
Recent studies have demonstrated that myelodysplastic syndromes (MDSs) arise from a
small population of disease-initiating hematopoietic stem cells (HSCs) that persist and …

The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications

H Medyouf - Blood, The Journal of the American Society of …, 2017 - ashpublications.org
Similar to their healthy counterpart, malignant hematopoietic stem cells in myeloid
malignancies, such as myeloproliferative neoplasms, myelodysplastic syndromes, and acute …